WeVote
Log In

Bill

Bill

S 4696

Prohibits health insurance carriers from obtaining pharmacy benefits manager licenses.

2024-2025 Regular Session Introduced by Vin Gopal and 1 co-sponsor

New Jersey bill bars health insurers from holding pharmacy benefits manager licenses, separating two industries to reduce conflicts of interest in prescription drug pricing.

Introduced in the Senate, Referred to Senate Commerce Committee
#healthinsur
0
WeVote Research Nonpartisan
Bill Summary · S 4696

Legislative bill overview

S 4696 prohibits health insurance carriers from obtaining or holding pharmacy benefits manager (PBM) licenses in New Jersey. This creates a structural separation between the insurance and PBM business lines, preventing a single entity from operating in both sectors simultaneously.

Why is this important

Vertical integration between insurers and PBMs has drawn scrutiny from policymakers and consumer advocates who argue it can lead to higher drug costs, reduced transparency, and conflicts of interest. By mandating separation, the bill aims to reduce these concerns and potentially increase competition in the PBM marketplace, which could affect prescription drug pricing and patient access.

Potential points of contention

  • Industry opposition: Large health insurers with PBM subsidiaries (like UnitedHealth/Optum) would face significant restructuring costs and operational complexity, likely generating strong lobbying against the measure
  • Market impact uncertainty: Critics may argue that forced separation could reduce operational efficiencies, potentially raising insurance premiums rather than lowering drug costs
  • Grandfather clause questions: The bill's language doesn't clarify whether existing integrated operations receive exemptions, transition periods, or divestiture timelines, creating enforcement ambiguity

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.